Recombinant tetanus vaccine (E. coli)

重组破伤风疫苗（大肠埃希菌）

Report date: 2024/08/13 14:34:46

Base Information

Drug NameRecombinant tetanus vaccine (E. coli)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYuanda Weixin Life Science (Nanjing) Co LtdFar contest Weixin Life Science (Hangzhou) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesFar contest Weixin Life Science (Hangzhou) Co LtdYuanda Weixin Life Science (Nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A